ICU sedation, delirium & recovery

Cost-Effectiveness of α2 Agonists for Intravenous Sedation in Patients With Critical Illness

JAMA Netw OpenPublished Economic evaluation (within-trial cost-utility analysis) of the A2B randomised trial

Authors' conclusion

In this study, dexmedetomidine-, clonidine-, and propofol-based IV sedation in patients with critical illness receiving mechanical ventilation had similar costs and QALYs.

Study context

Population
Adults with critical illness receiving mechanical ventilation, anticipated ≥2 days of ventilation, 41 UK ICUs
Participants
1,404 adults
Comparison
Dexmedetomidine- or clonidine-based vs propofol-based intravenous (IV) sedation
Primary endpoint
Incremental costs and quality-adjusted life years (QALYs) gained (dexmedetomidine vs propofol, clonidine vs propofol); mean net monetary benefits
Follow-up
6 months
Methodological details6-month time horizon, UK NHS and Personal Social Services perspective, individual-level trial data, 41 ICUs, Recruitment December 2018 through October 2023; last follow-up December 10, 2023
  • 6-month time horizon
  • UK NHS and Personal Social Services perspective
  • Individual-level trial data
  • 41 ICUs
  • Recruitment December 2018 through October 2023; last follow-up December 10, 2023

Primary result

As reported in the abstract

Incremental cost

Incremental cost

1273 $

95% CI -$5000 to $7545

Dexmedetomidine

Incremental cost

−1328 $

95% CI -$7114 to $4459

Clonidine

Further findings

OutcomeDexmedetomidineClonidinePropofolQALYs gained (QALYs) (95% CI)
QALYs gainedDexmedetomidine vs Propofol0.0008 (−0.0198 to 0.0214)
QALYs gainedClonidine vs Propofol−0.0019 (−0.0221 to 0.0181)
Mean net monetary benefit (willingness to pay $16 250 per QALY)mean -$53 278 (95% CI -$58 063 to -$48 493)mean -$50 882 (95% CI -$55 003 to -$46 762)mean -$52 036 (95% CI -$56 230 to -$47 834)

Original publication

Cost-Effectiveness of α2 Agonists for Intravenous Sedation in Patients With Critical Illness. JAMA Netw Open. Published 1 May 2025. doi:10.1001/jamanetworkopen.2025.17533

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.